Learn More
Apexbio Technology LLC VX-222 (VCH-222, Lomibuvir) 1026785-59-0 100mg

Supplier: Apexbio Technology LLC A4032100
VX-222 (VCH-222 Lomibuvir) is a non-nucleoside inhibitor of hepatitis C virus (HCV) RNA polymerase functioning through direct interaction with the polymerase enzyme It targets the thumb II allosteric pocket of the HCV RNA-dependent RNA polymerase (NS5B) mediating inhibition specifically by interfering with primer-dependent RNA synthesis rather than de novo initiation The inhibitory mechanism is attributed to hydrophobic interactions between its 4-methylcyclohexyl moiety and residues L412 M423 and I482 within the polymerase domain VX-222 demonstrates variable inhibitory activities in biochemical assays exhibiting IC50 values ranging from 0 011 to greater than 5 M depending on RNA template conditions making it suitable for antiviral mechanism and viral replication studies
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.